EXCEED THE SPACE PROVIDED. IL-12 is a cytokine, critical for type 1 cellular immunity that is strongly implicated in the pathogenesis of inflammatory neurological diseases such as multiple sclerosis (MS). In the previous funding periods we showed that IL-12 can be produced by microglia and to a lesser extent by astrocytes, suggesting that localized IL-12 may regulate cellular immune responses in the CNS. To test this further, transgenic mice were generated with astrocyte-production of bioactive IL-12. These GF-IL12 mice develop neurologic disease in association with active type 1 cellular immune pathology in the brain. These and subsequent findings confirm that local production of IL-12 can initiate and drive spontaneous as well as target peripherally induced type I adaptive and innate cell-mediated immune responses in the CNS. The GF-IL12 mice are a unique and valuable new paradigm in which we now propose to study basic mechanisms of action of IL-12 in the brain as well as investigate specific processes underlying the localization, extravasation and activation of immune cells in the CNS and the subsequent interactions between these cells which contdbute to CNS damage. Consistent with this goal here we propose to: (1) determine the expression, regulation and role of the IL-12 receptor (IL-12R) and the signal transducers and activators of transcription (STAT) and suppressors of cytokine signaling (SOCS) in the development of the clinical, cellular and molecular alterations in the CNS of the GF-IL12 mice, (2) elucidate the role of IL-12-induced IFN-gamma production by mononuclear cells in the development of spontaneous and induced cellular immune responses in the brain of the GF-IL12 mice, (3) clarify whether or not and what role is played by NK cells versus antigen-specific autoimmune T-cell responses in the development of immune-mediated disease pathology in the CNS of the GF-IL12 mice. (4) To investigate whether antigen presentation can occur from within the brain driven by the local production of IL-12. The studies outlined in this continuing proposal will provide valuable new knowledge concerning the role of IL-12 in regulating molecular and cellular processes involved in cellular immune responses in the CNS. They are extremely relevant to our understanding of the pathogenesis of a wide spectrum of neurologic disorders that involve cellular immune responses in the CNS. Finally, the results from these studies could lay the conceptual foundations for the development of novel therapeutic approaches to ameliorate CNS diseases of immunoinflammatory origin in which IL-12 is implicated. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS036979-08
Application #
6819724
Study Section
Special Emphasis Panel (ZRG1-SSS-P (01))
Program Officer
Utz, Ursula
Project Start
1997-12-01
Project End
2007-11-30
Budget Start
2004-12-01
Budget End
2005-11-30
Support Year
8
Fiscal Year
2005
Total Cost
$256,500
Indirect Cost
Name
University of Sydney
Department
Type
DUNS #
752389338
City
Sydney
State
Country
Australia
Zip Code
2006
Campbell, Iain L; Hofer, Markus J; Pagenstecher, Axel (2010) Transgenic models for cytokine-induced neurological disease. Biochim Biophys Acta 1802:903-17
Feuer, Ralph; Ruller, Chelsea M; An, Naili et al. (2009) Viral persistence and chronic immunopathology in the adult central nervous system following Coxsackievirus infection during the neonatal period. J Virol 83:9356-69
Mauermann, Michelle L; Amrami, Kimberly K; Kuntz, Nancy L et al. (2009) Longitudinal study of intraneural perineurioma--a benign, focal hypertrophic neuropathy of youth. Brain 132:2265-76
Getts, Daniel R; Terry, Rachael L; Getts, Meghann Teague et al. (2008) Ly6c+ ""inflammatory monocytes"" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med 205:2319-37
Hofer, Markus J; Carter, Sally L; Muller, Marcus et al. (2008) Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-Armstrong. Viral Immunol 21:425-33
Quintana, Albert; Molinero, Amalia; Florit, Sergi et al. (2007) Diverging mechanisms for TNF-alpha receptors in normal mouse brains and in functional recovery after injury: From gene to behavior. J Neurosci Res 85:2668-85
Getts, Daniel R; Matsumoto, Izuru; Muller, Marcus et al. (2007) Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures. J Neurochem 103:1019-30
Millward, Jason M; Caruso, Maria; Campbell, Iain L et al. (2007) IFN-gamma-induced chemokines synergize with pertussis toxin to promote T cell entry to the central nervous system. J Immunol 178:8175-82
Crocker, Stephen J; Milner, Richard; Pham-Mitchell, Ngan et al. (2006) Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells. J Neurochem 98:812-23
Crocker, Stephen J; Whitmire, Jason K; Frausto, Ricardo F et al. (2006) Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1-deficient mice. Am J Pathol 169:2104-16

Showing the most recent 10 out of 34 publications